WHO ICTRP trial
Pathogenic Antibodies and (Rapidly Progressive) Dementia syndromes
NL-OMON47904 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON47904 |
|---|---|
| Public title | Pathogenic Antibodies and (Rapidly Progressive) Dementia syndromes |
| Scientific title | Pathogenic Antibodies and (Rapidly Progressive) Dementia syndromes - PARADE study |
| Primary sponsor | Erasmus MC, Universitair Medisch Centrum Rotterdam |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | autoimmune encephalitis inflamed brain;10003816;10007951;10037173;autoimmune encephalitis;inflamed brain |
| Interventions | ;antibodies;autoimmune;dementia;encephalitis |
| Registration date | Mar 20, 2019 |
| Target size | 300 |
| Secondary IDs | NL58014.078.18 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: